Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): Induction of protective tolerance in primed animals

Clinical and Experimental Immunology

Volumn 109, Issue 2, 1997, Pages 370-376

  Thurau, S R ^a,b   Chan, C C ^a   Nussenblatt, R B ^a   Caspi, R R ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Autoantigens; Chronic relapsing autoimmune uveitis; Oral tolerance; T lymphocytes

Indexed keywords

AUTOANTIGEN; RETINA ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; ETIOLOGY; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; UVEORETINITIS;

EID: 0030757911     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4571356.x     Document Type: Article

References (40)

1. Nussenblatt RB, Palestine AG, El-Saied M, Meyers S, Lando Z, Muellenberg C, Rozenszajn LA. Long-term antigen specific and non-specific T-cell lines and clones in uveitis. Curr Ey Res 1984; 3:299-305.
2. de Smet MD, Yamamoto JH, Mochizuki M et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 1990; 110:135-42.
3. Wildner G, Thurau SR. Crossreactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol 1994; 24:2579-85.
4. Nussenblatt RB, Palestine AG, Rook AH, Scher I, Wacker WB, Gery I. Treatment of intraocular inflammatory disease with cyclosporin A. Lancet 1983; 2:235-8.
5. Thurau SR, Wildner G, Reiter C, Riethmüller G, Lund OE. Treatment of endogenous uveitis with anti CD4-monoclonal antibody: first report. German J Ophthalmol 1994; 3:409-13.
6. Gery I, Mochizuki M, Nussenblatt RB. Retinal specific antigens and immunopathogenic processes they provoke. In: Osborne N, Chader J, eds. Progress in retinal research. Oxford: Pergamon Press, 1986; 75-109.
7. Caspi RR, Chan CC, Leake WC, Higuchi M, Wiggert B, Chader GJ. Experimental autoimmune uveoretinitis in mice. Induction by a single eliciting event and dependence on quantitative parameters of immunization. J Autoimmun 1990; 3:237-46.
8. Chan CC, Caspi RR, Ni M, Leake WC, Wiggert B, Chader GJ, Nussenblatt RB. Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun 1990; 3:247-55.
9. Dakin R. Remarks on a cutaneous affection, produced by certain poisonous vegetables. Am J Med Sci (old series) 1829; 4:98.
10. Thompson HS, Staines NA. Could specific oral tolerance be a therapy for autoimmune disease? Immunol Today 1990; 11:396-9.
11. Nussenblatt RB, Caspi RR, Mahdi R, Chan CC, Roberge F, Lider O, Weiner HL. Inhibition of S-Antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-Antigen. J Immunol 1990; 144: 1689-95.
12. Rizzo LV, Miller-Rivero NE, Chan CC, Wiggert B, Nussenblatt RB, Caspi RR. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest 1994; 94:1668-72.
13. Gregerson DS, Obritsch WF, Donoso LA. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs. high dose feeding protocols. J Immunol 1993; 151:5751-61.
14. Melamed D, Friedman A. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression. Eur J Immunol 1994; 24:1974-81.
15. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994; 91:6688-92.
16. Melamed D, Fishman-Lobell J, Uni Z, Weiner HL, Friedman A. Periperal tolerance of Th2 lymphocytes induced by continuous feeding ovalbumin. Int Immunol 1996; 8:717-24.
17. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science (Wash. DC) 1993; 259:1321-4.
18. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi C, Lorenzo C, Sewell KL, Hafler DA, Weiner HL. Effects of oral administration of type II collagen on rheumatoid arthritis. Science (Wash. DC) 1993; 261:1727-30.
19. Sieper J, Kary S, Sorensen H et al. Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial. Arthritis Rheum 1996; 39:41-51.
20. Adler AJ, Chader GJ, Wiggert B. Purification and assay of interphotoreceptor retinoid-binding protein from the eye. Methods Enzymol 1990; 189:213-23.
21. Redmond TM, Wiggert B, Robey FA, Nguyen NY, Lewis MS, Lee L, Chader GJ. Isolation and characterization of monkey interphotoreceptorretinoid-binding protein, a unique extracellular matrix component of the retina. Biochemistry 1985; 24:787-93.
22. Lämmli UK. Cleavage of structural proteins during the assembly of proteins of the head of bacteriophage T4. Nature 1970; 227:680-5.
23. Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 1988; 140:1490-5.
24. Caspi RR, Kuwabara T, Nussenblatt RB. Characterization of a suppressor cell line which downgrades experimental autoimmune uveoretinitis in the rat. J Immunol 1988; 140:2579-84.
25. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991; 147:2155-63.
26. Miller A, Lider O, Roberts AB, Spoon MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Natl Acad Sci USA 1992; 89:421-5.
27. Nagler-Anderson CN, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 1986; 83:7443-6.
28. Khare SD, Krco CJ, Pawelski JR, Griffith MM, Luthra HS, David CS. Oral administration of human collagen peptide 250-270 suppresses collagen-induced arthritis in DBA/1 mice by inhibiting a Th1 response. Arthritis Rheum 1994; 37:S398.
29. Staines NA. Oral tolerance and collagen arthritis. Brit J Rheumatol 1991; 30(Suppl. 2):40.
30. Wildner G, Thurau SR. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye. Eur J Immunol 1995; 25:1292-7.
31. Gregerson DS, Obritsch WF, Donoso LA. Oral tolerance in experimental autoimmune uveoretinitis. J Immunol 1993; 151:5751-61.
32. Thurau SR, Chan CC, Suh E, Nussenblatt RB. Induction of oral tolerance to S-Antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide. J Autoimmun 1991; 4:507-16.
33. Wildner G, Thurau SR. A disease-associated MHC-peptide sharing sequence homologies with autoantigen: defining tolerogenic epitopes by oral tolerance induction. Immunobiology 1995; 194:159-60.
34. + cells suppress experimental autoimmune uveitis. Eur J Immunol 1996; 26:2140-8.
35. Lamont AG, Bruce MO, Watret KC, Ferguson A. Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology 1988; 64:135-9.
36. Brod SA, Al-Sabbagh A, Sobel RA, Hafler DA, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens. IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann Neurol 1991; 29:615-22.
37. Hämmerling GJ, Schönrich G, Ferber I, Arnold B. Peripheral tolerance as a multi-step mechanism. Immunol Rev 1993; 133:93-104.
38. Wannemuehler MJ, Kiyono H, Babb JL, Michalek SM, McGhee JR. Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J Immunol 1982; 129:959-65.
39. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Röcken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994; 180:1961-6.
40. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176:1355-64.